The Evidence Our Science

Golden Sunrise Nutraceutical (Golden Sunrise) produces dietary supplement products that through innovative technology of Cellular Therapy are based on the principles of Quantum Biology (Technology).

The Technology is based on: Tieu Equation + Einstein Equation + Schrodinger Equation = New Innovation Quantum Technology.  The Tieu Equation is a concept within Quantum Biology that aims to describe how Quantum Mechanics can be applied to biological systems, the Einstein Equation represents the fundamental relationship between mass and energy, and the Schrodinger Equation is a core equation in Quantum Mechanics that describes the wave function of a particle, essentially defining its state and behavior at the quantum level.

CLINICAL PHARMACOLOGY AND THERAPEUTICS

Mechanism of Action of novel Technology is important for several reasons: 

* The Technology which helps in cell division and the regeneration cells of promotes the cellular metabolism to return to Homeostasis in the human structure.  It is postulated that in arresting abnormal cellular mutation, enhanced cellular regeneration, and cellular division can be accelerated in relation to the selective existing disease pathology.  It is therefore theorized that the combination of the body's thermal energy, particularly during variance mutation and inflammatory processes, potentiated the self-propelling of molecules by possible passive membrane transportation or passive diffusion of the Technology intact across all cell membranes.  This also includes permeation that crosses the blood-brain barrier, which allows its functionality for the central nervous system;

* The Technology is readily adsorbed into soft tissue when taken as an oral dose.  The Technology possess a bipolarity and a lipophilicity that facilitates molecular diffusion through various permeable and selective membranes.  In-vivo studies on test subjects have indicated that the cell membrane integrity remains intact and is not disrupted or destroyed in the process of assimilating into the cell, thus ensuring long-term effectiveness on the immune system and cellular metabolism.  They have immune-stimulating properties.  In-vivo studies on treated chronic disease patients indicate increasing phagocytic activity and synthesis of helper cell function.  The Technology have shown to transform Deoxyribonucleic acid (DNA) and Ribonucleic acid (RNA) repair, before, during and after chemotherapy drugs, toxic exposure, and chemical induced damage.  The Technology have a variety including anti-oxidant activity and anti-inflammatory properties; and

* The Technology can play an integral role in hypothalamic activity, easing both parasympathetic and sympathetic nervous systems towards a state of homeostasis.  For example, blood pressure level is directly linked to the sympathetic nervous system.  The normalizing of blood pressure levels exhibited following administration of the Technology is compatible with the stabilization of the sympathetic nervous system activity.  The Technology reduces inflammation by affecting immune responsiveness through neuroendocrine factors. Improvement of balance problems, a side-effect of some chemotherapies, by the Technology is thought to be from improvement of vestibular function.

Pharmacokinetics: The Technology is readily adsorbed into soft tissue when taken as an oral dose.  This is accomplished because the Technology readily passes through membrane tissue by passive diffusion.  The Technology is metabolized by the body to more hydrophilic products that are excreted by the kidneys in the urine and by the gastrointestinal tract in the feces.

* The Technology have produced significant drop in blood sugar levels.  Documented drop in blood sugar has occurred from 440 mg/dL to 60 mg/dL in less than two hours without the patient experiencing any symptoms such as dizziness, weakness, sweating, etc., and still carry on the usual daily activities.  Cancer cell metabolism requires glucose for the fermentation process to produce its energy for growth and development.  This drop in blood glucose arrests the fermentation process and the cancer cell;

* The Technology have affected bone metabolism by demonstrating improved bone density in patient with osteoporotic bone.  Numbers based on densitometry have shown a reversal in L1-L4 from -3.6% to 3.4% in 2-years;

* The subject began taking the Technology to help with blood loss.  Operation of surgery results were minimal blood loss of less than 25ml is associated with lower risks of complications;

* The Technology has reduced or eliminated jet lag and allowed a normal sleep regiment despite crossing new time zones;

* Red Blood Cell and Platelet Cell Test Results; Purpose: Patient with Lymphocytic Leukemia is a 69-year-old white male who has  been treated for chronic Lynphocytic Leukemia for the last five years.  He started taking substance in October, 2015.  This was because of the  concern about falling red blood cell counts and platelet counts.  His  white blood cell count, though elevated remained elevated, and  fluctuant.  Conclusion: In October, 2015 his red blood cell count was 4.05 and his platelet count was 90.  In April, 2016 his red blood cell count was 4.19 and his platelet count was 105.  It was felt that this was a signification increase in both his red blood cell count and platelet count; and

* The Technology can help with bone growth as referenced in the articles publication "Tieu Equation" and "Particle Becomes Energy = Energy Becomes Mass".